Sofinnova Ventures »

Inhibrx Biosciences shares owned by Sofinnova Ventures

Quarter-by-quarter ownership of Inhibrx Biosciences shares owned by Sofinnova Ventures from 13F filings

Historical chart of Sofinnova Ventures investment in Inhibrx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Inhibrx Biosciences held by Sofinnova Ventures consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibrx Biosciences by Sofinnova Ventures

Quarter filed Position value Share count Share price at filing
2024-06-30 $6.6M 463k 14.17

More positions owned by Sofinnova Ventures

Invesco QQQ TR Unit Ser 1 Put Option (QQQ)
Natera (NTRA)
Edwards Lifesciences (EW)
Vera Therapeutics Cl A (VERA)
Ascendis Pharma A/S Sponsored Adr (ASND)
Novo-Nordisk A S Adr (NVO)
Stryker Corporation (SYK)
AstraZeneca Sponsored Adr (AZN)
Intuitive Surgical (ISRG)
Dyne Therapeutics (DYN)
Align Technology (ALGN)
Alnylam Pharmaceuticals (ALNY)
Rapport Therapeutics
Syndax Pharmaceuticals (SNDX)
Elanco Animal Health (ELAN)

View all positions for Sofinnova Ventures

Top funds holding Inhibrx Biosciences

Viking Global Investors
Perceptive Advisors
BlackRock
Vanguard Group
Sofinnova Ventures
Slotnik Capital
Alpine Associates Management
Millennium Management
TIG Advisors
Morgan Stanley
Ikarian Capital
Geode Capital Management
Caption Management
Marshall Wace
CSS

View all funds holding Inhibrx Biosciences